|
RIOK3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.199400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.373520E-02 |
| Normal-vs-Stage2 |
1.759150E-01 |
| Normal-vs-Stage3 |
6.105000E-01 |
| Normal-vs-Stage4 |
2.784600E-01 |
| Stage1-vs-Stage2 |
9.575800E-01 |
| Stage1-vs-Stage3 |
6.096000E-01 |
| Stage1-vs-Stage4 |
1.253800E-02 |
| Stage2-vs-Stage3 |
6.400400E-01 |
| Stage2-vs-Stage4 |
6.844000E-02 |
| Stage3-vs-Stage4 |
3.155200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.701860E-02 |
| Normal-vs-AfricanAmerican |
1.309770E-01 |
| Normal-vs-Asian |
8.155000E-01 |
| Caucasian-vs-AfricanAmerican |
6.040200E-01 |
| Caucasian-vs-Asian |
4.494800E-01 |
| AfricanAmerican-vs-Asian |
4.190800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.557900E-03 |
| Normal-vs-Female |
2.176400E-01 |
| Male-vs-Female |
3.338400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.857800E-01 |
| Normal-vs-Extreme_Weight |
2.035600E-01 |
| Normal-vs-Obese |
1.698790E-01 |
| Normal-vs-Extreme_Obese |
8.532100E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.123600E-01 |
| Normal_Weight-vs-Obese |
6.850200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.212400E-01 |
| Extreme_Weight-vs-Obese |
8.466800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.431000E-01 |
| Obese-vs-Extreme_Obese |
4.000200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.719600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.864520E-03 |
| Normal-vs-Age(61-80Yrs) |
1.083430E-01 |
| Normal-vs-Age(81-100Yrs) |
9.585000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.204000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.274000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.171000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.583810E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.837180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.112000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.241790E-04 |
| Normal-VS-Type2 PRCC |
6.421600E-01 |
| Normal-VS-KIRP CIMP |
3.264100E-02 |
| Normal-VS-Unclassified PRCC |
2.858000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.262300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.339500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.032800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.327700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.693200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.147390E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.537650E-01 |
| Normal-vs-N1 |
7.258000E-01 |
| Normal-vs-N2 |
8.051500E-02 |
| N0-vs-N1 |
2.259200E-01 |
| N0-vs-N2 |
1.966580E-01 |
| N1-vs-N2 |
5.528400E-01 |
|
|
